GlobeNewswire

Cisco Tetration Workload Protection Extended with New Options: SaaS and Virtual Appliance

Dela

New Tetration models deliver faster deployment and pay-as-you-grow flexibility

 

SAN JOSE, Calif., April 10, 2018 (GLOBE NEWSWIRE) -- Cisco today announced two new consumption models for its Cisco® Tetration solution for the data center and cloud: Tetration SaaS, the cloud-based solution for cloud-first and cloud-only organizations, and Tetration-V, a software-only version using a virtual appliance for smaller deployments. Both models deliver the same features and functionality as the original on-premises form factors of Tetration. Tetration automates application dependency mapping and whitelist policy generation and enforcement, gives insight into network performance, and offers cloud workload protection. The Tetration  APIs enable IT organizations to create custom applications with access to Tetration data sources, allowing the export and enforcement of policies generated by Tetration across SDN controllers and security devices.

With the new consumption models, organizations can adopt Tetration technology within hours, with no initial investment and the flexibility to pay as they grow.

With Tetration SaaS, organizations gain the benefits of a fully managed model, including:

  • Workload protection features without any on-premises hardware requirements
  • Protection for on-premises, public, and private cloud workloads
  • Scalability up to 25,000 workloads
  • Data retention for months
  • Faster onboarding to realize the benefits of the platform quickly
  • Built-in high availability and disaster recovery capability
  • Service backed by world-class SLAs
  • Managed services provided by Cisco channel partners

For organizations that deploy fewer than 1000 workloads and prefer a software-only approach, Tetration is available on a virtual appliance. It offers one-click deployment and allows organizations to use their own server and storage infrastructure. 

Both Tetration models deliver a ready-to-use solution to identify data center applications, their detailed dependencies, and the underlying policies between different application tiers. Operators can implement a zero-trust model using whitelist policy and segmentation, monitor the behavior of server processes, and identify software-related vulnerabilities. Tetration is able to identify high-severity security events such as certain Spectre and Meltdown exploits using behavior-based anomalies, allowing proactive quarantining of affected servers. With this approach, Tetration provides holistic cloud workload protection anywhere. For more information, see A Recipe to Keep Your Hybrid Cloud Workloads Safe.

"Cisco Tetration helps Xentaurs manage successful cloud and data center deployments for our clients by ensuring every single connection and flow to an application is visible," said Anoj Willy, CEO, Xentaurs. "Without this critical information, app, cloud, and data center migrations would be impossible to precisely guarantee nothing is missed and everything is as it is intended. Tetration goes further in establishing and enforcing a zero-trust environment that is the foundation for microsegmentation, down to containers and next-generation services development."

Cisco's architectural approach to security 
Tetration is also a core technology in Cisco's data center security and workload protection portfolio. Tetration works with Cisco ACI and Cisco's security portfolio, including Cisco Firepower® Next-Generation Firewall (NGFW), Next-Generation IPS (NGIPS), Advanced Malware Protection (AMP), and Stealthwatch® to deliver effective security that follows the workload everywhere. Now operators can see everything across their network, reduce the attack surface, and stop data center breaches from moving laterally across workloads.  For more information, see Redefining Security for the Modern Data Center in a Multi-Cloud World.

Cisco Services for Tetration
If requested, Cisco can also provide professional and support services for Tetration SaaS and Tetration-V, including: support for Tetration onboarding and use-case support to accelerate Tetration adoption and optimize policies and security, resulting in a faster time to value with Tetration.  

Availability
Cisco Tetration SaaS is scheduled to be available in May 2018. Tetration-V is available now. 

Additional resources   
Learn more about Cisco TetrationLearn more about Cisco ACI(TM)
Learn more about Cisco ACI ecosystem partnersLearn more about Cisco data center technologyLearn more about Services for Cisco Tetration

About Cisco
Cisco (NASDAQ:CSCO) is the worldwide technology leader that has been making the Internet work since 1984. Our people, products, and partners help society securely connect and seize tomorrow's digital opportunity today. Discover more at thenetwork.cisco.com and follow us on Twitter at @Cisco.

Cisco and the Cisco logo are trademarks or registered trademarks of Cisco and/or its affiliates in the U.S. and other countries. A listing of Cisco's trademarks can be found at www.cisco.com/go/trademarks. Third-party trademarks mentioned are the property of their respective owners. The use of the word partner does not imply a partnership relationship between Cisco and any other company.

RSS Feed for Cisco: http://newsroom.cisco.com/rss-feeds

Press Relations: 
Lee Davis   
Cisco 
650-868-3036
leedavis@cisco.com             
Analyst Relations:
Aimee Schoaf 
Cisco 
623-377-0377
aschoaf@cisco.com             
Investor Relations:
Carol Villazon
Cisco
408-527-6538
carolv@cisco.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Cisco via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Iconovo: kundprojekt blir framflyttat tre till sex månader8.11.2018 15:45Pressmeddelande

Fortsatt arbete med ett av Iconovos pågående kundprojekt kommer att flyttas fram tre till sex månader. Projektet avser utveckling av produkt anpassad för kund som ska svara för produktion och marknadslansering. Det aktuella arbetet var planerat att ske under fjärde kvartalet men beräknas ske under nästa år, och detta påverkar Iconovos omsättning under 2018 negativt med cirka 2 miljoner kronor. Orsaken är att kunden har beslutat att genomföra en mindre klinisk studie för att verifiera produkten innan nästa steg tas vilken omfattar investeringar i betydande mångmiljonbelopp i produktionskapacitet, baserat på Iconovos utveckling. Studien görs för kundens egna räkning och är inte villkorad av tillsynsmyndigheter. "Detta påverkar vårt resultat på kort sikt, men det faktum att kunden har beslutat att göra en betydande investering i faktisk produktion betyder att vi med stor säkerhet kan se fram emot licensintäkter under en lång tidsrymd framöver i samband med att produkten lanseras på markna

Stillfront Group AB: Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 20187.11.2018 14:34Pressmeddelande

PRESSMEDDELANDE 7 november 2018 Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 2018 Stillfront Groups kvartalsrapport för det tredje kvartalet 2018 kommer att publiceras klockan 07.00 den 22 november 2018. En webbsänd telefonkonferens kommer att hållas klockan 10.00 samma dag där Jörgen Larsson, VD och Sten Wranne, CFO, kommenterar resultatet. Presentationen och rapporten kommer efter presentationen att finnas tillgänglig på www.stillfront.com Webbsändningen nås på adressen: https://tv.streamfabriken.com/stillfront-q3-2018 För att delta via telefon, vänligen ring: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FÖR YTTERLIGARE INFORMATION, VÄNLIGEN KONTAKTA: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com OM STILLFRONT Stillfront är en oberoende utvecklare, förläggare och distributör av digitala spel - med visionen att bli en ledande indie-spelutvecklare och förläggare. Stillfront är verksamt genom tio näst intill självständiga dotte

Stillfront Group AB: Invitation to Stillfront Group Q3 presentation7.11.2018 14:34Pressmeddelande

Invitation to Stillfront Group Q3 presentation Stillfront Group interim report for the third quarter 2018 will be published at 07.00 CET on 22 November 2018. A presentation of the report will be held the same day at 10.00 CET via telephone conference or audiocast where Jörgen Larsson, CEO and CFO Sten Wranne are to comment on the report. The presentation can be viewed live at https://tv.streamfabriken.com/stillfront-q3-2018 To participate via phone please call: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FOR FURTHER INFORMATION, PLEASE CONTACT: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com ABOUT STILLFRONT Stillfront is a group of independent creators, publishers and distributors of digital games - with a vision to become the leading group of indie game creators and publishers. Stillfront operates through ten near-autonomous subsidiaries: Bytro Labs in Germany, Coldwood Interactive in Sweden, Power Challenge in the UK and Sweden, Dorado Online Games

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Oboya participates in China International Import Expo1.11.2018 15:00Pressmeddelande

Newsletter Lerum, 1th November 2018 Oboya Horticulture Industries AB (publ) ("Oboya"), a global manufacturer and supplier of products and services for the cultivation industry, will participate in China International Import Expo in Shanghai, China. China International Import Expo (CIIE) is a six-day fair held from November 5 to November 10, 2018 at the National Convention & Exhibition Center in Shanghai, China. This fair brings together companies, exhibitors and professional buyers from all over the world. The fair creates new channels for companies from different countries and regions and provides the opportunity to do business, strengthen cooperation and promote trade. Oboya's strategy is to work globally in the various markets in the cultivation and flower industry, which it's important for Oboya to participate in the major trade shows. Oboya has its own booth at the fair and will show/marketing the European cultivation products and technology to the Chinese market. The purpose of t

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum